Core to Evidence-Based Health Policy
cost-effectiveness evaluation for future healthcare
C2H is the only public research organization
for official cost-effectiveness evaluation process
in Japan
C2H (Center for Outcomes Research and Economic Evaluation for Health) is an organization of National Institute of Public Health; it conducts academic analysis of cost-effectiveness evaluation from the scientific viewpoint. This website will dispatch information about cost-effectiveness evaluation in Japan. We are happy if this website contributes to evidence-based health policy (EBHP).
Tools for cost-effectiveness evaluation
Latest news
-
news
The first reports of the cost-effectiveness evaluation were released.
Reports of the cost-effectiveness evaluation on Fluticasone/Umeclidinium/Vilanterol (Trelegy) and Tisagenlecleucel (Kymriah) were released. These are our first reports since this HTA system was started from April 2019 in Japan.
-
news
Guidelines for analysis of cost-effectiveness evaluation published
In ”Tools,” we have published the “Guideline for Preparing Cost-Effectiveness Evaluation to the Central Social Insurance Medical Council” approved by the Chuikyo General Assembly on February 20, 2019.
-
news
Materials from the International Symposium have been posted
Materials presented at the International Symposium on the Current Status and Future Role of HTA in Japan and Other Countries held on Monday, February 25, 2019 have been posted.